InGell Labs is well prepared for delivering animal trial material both concerning the pure polymer as well as formulated with the active pharmaceutical ingredient. All critical preparations are done in clean rooms for low bioburden and low endoxtin content. An extensive analytical package is being applied for detailed understanding of the sample characteristics.
Through InGell's partnership with PolyVation the pure polymers can be made available for human clinical trials. The required cGMP rules become implemented with growing stringency going from Phase I to III.
Through InGell's partnership with InnoCore facilities are coming into place for delivering formulated materials for use in human clinical trials. Depending on the type of active ingredient this may also be outsoursed to other selected partners.